These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 11191059)
1. The contributions of cyclooxygenase-2 to tumor angiogenesis. Gately S Cancer Metastasis Rev; 2000; 19(1-2):19-27. PubMed ID: 11191059 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis. Gately S; Kerbel R Prog Exp Tumor Res; 2003; 37():179-92. PubMed ID: 12795055 [TBL] [Abstract][Full Text] [Related]
3. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Gately S; Li WW Semin Oncol; 2004 Apr; 31(2 Suppl 7):2-11. PubMed ID: 15179620 [TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. Hernández GL; Volpert OV; Iñiguez MA; Lorenzo E; Martínez-Martínez S; Grau R; Fresno M; Redondo JM J Exp Med; 2001 Mar; 193(5):607-20. PubMed ID: 11238591 [TBL] [Abstract][Full Text] [Related]
5. Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer. Chu J; Lloyd FL; Trifan OC; Knapp B; Rizzo MT Mol Cancer Ther; 2003 Jan; 2(1):1-7. PubMed ID: 12533667 [TBL] [Abstract][Full Text] [Related]
6. Re: Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. Gallo O J Natl Cancer Inst; 2000 Feb; 92(4):346-7. PubMed ID: 10675387 [No Abstract] [Full Text] [Related]
7. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Gallo O; Franchi A; Magnelli L; Sardi I; Vannacci A; Boddi V; Chiarugi V; Masini E Neoplasia; 2001; 3(1):53-61. PubMed ID: 11326316 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198 [TBL] [Abstract][Full Text] [Related]
9. [Endogenous prostaglandins and angiogenesis]. Majima M; Amano H; Hayashi I Nihon Yakurigaku Zasshi; 2001 Apr; 117(4):283-92. PubMed ID: 11338378 [TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2: a therapeutic target in angiogenesis. Iñiguez MA; Rodríguez A; Volpert OV; Fresno M; Redondo JM Trends Mol Med; 2003 Feb; 9(2):73-8. PubMed ID: 12615041 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Cianchi F; Cortesini C; Bechi P; Fantappiè O; Messerini L; Vannacci A; Sardi I; Baroni G; Boddi V; Mazzanti R; Masini E Gastroenterology; 2001 Dec; 121(6):1339-47. PubMed ID: 11729113 [TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Daniel TO; Liu H; Morrow JD; Crews BC; Marnett LJ Cancer Res; 1999 Sep; 59(18):4574-7. PubMed ID: 10493510 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Liu XH; Kirschenbaum A; Yao S; Stearns ME; Holland JF; Claffey K; Levine AC Clin Exp Metastasis; 1999; 17(8):687-94. PubMed ID: 10919714 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. Liu XH; Kirschenbaum A; Yao S; Lee R; Holland JF; Levine AC J Urol; 2000 Sep; 164(3 Pt 1):820-5. PubMed ID: 10953162 [TBL] [Abstract][Full Text] [Related]
15. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Majima M; Hayashi I; Muramatsu M; Katada J; Yamashina S; Katori M Br J Pharmacol; 2000 Jun; 130(3):641-9. PubMed ID: 10821793 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells. Li G; Yang T; Yan J Biochem Biophys Res Commun; 2002 Dec; 299(5):886-90. PubMed ID: 12470662 [TBL] [Abstract][Full Text] [Related]
17. Thalidomide, cyclooxygenase-2, and angiogenesis: potential for therapy. Onn A; Tseng JE; Herbst RS Clin Cancer Res; 2001 Nov; 7(11):3311-3. PubMed ID: 11705841 [No Abstract] [Full Text] [Related]
18. Cyclooxygenase-2: a novel target for cancer chemotherapy? Dempke W; Rie C; Grothey A; Schmoll HJ J Cancer Res Clin Oncol; 2001 Jul; 127(7):411-7. PubMed ID: 11469677 [TBL] [Abstract][Full Text] [Related]
19. Induction of cyclooxygenase-1 and -2 modulates angiogenic responses to engagement of alphavbeta3. Murphy JF; Steele C; Belton O; Fitzgerald DJ Br J Haematol; 2003 Apr; 121(1):157-64. PubMed ID: 12670347 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]